Inventor · Dresden, DE

Klaus Dugi

18Patents
9h-index
24Co-inventors
68Inventor score

Filing activity: Oct 31, 2006 → Apr 27, 2022

Most-cited inventions

PatentTitleAreaCited byStatus
US8232281B2 Uses of DPP-IV inhibitors Human Necessities 105 Active
US8673927B2 Uses of DPP-IV inhibitors Human Necessities 62 Active
US8846695B2 Treatment for diabetes in patients with inadequate glycemic control despite metformin therapy comprising a DPP-IV inhibitor Human Necessities 45 Active
US8551957B2 Pharmaceutical composition comprising a glucopyranosyl-substituted benzene derivate Human Necessities 32 Active
US8853156B2 Treatment for diabetes in patients inappropriate for metformin therapy Human Necessities 28 Active
US9457029B2 Treatment of genotyped diabetic patients with DPP-IV inhibitors such as linagliptin Human Necessities 27 Active
US9173859B2 Uses of DPP IV inhibitors Human Necessities 26 Active
US9486526B2 Treatment for diabetes in patients inappropriate for metformin therapy Human Necessities 11 Active
US10034877B2 Treatment for diabetes in patients inappropriate for metformin therapy Human Necessities 11 Active
US7524822B2 Crystalline form of 1′-(1-methylethyl)-4′-[(2-fluoro-4-methoxyphenyl)methyl]-5′-methyl-1H-pyrazol-3′-O-β-D-glucopyranoside, a method for its preparation and the use thereof for preparing medicaments Human Necessities 8 Active
US10092571B2 Treatment of genotyped diabetic patients with DPP-IV inhibitors such as linagliptin Human Necessities 7 Active
US8202884B2 Treatment of type 2 diabetes Human Necessities 1 Active
US10668074B2 Uses of DPP IV inhibitors General 0 Revoked
US11291668B2 Uses of DPP IV inhibitors Human Necessities 0 Active
US12312352B2 Use of a DPP-4 inhibitor in SIRS and/or sepsis Human Necessities 0 Active
US7838500B2 Crystalline form of 1′-(1-methylethyl)-4′-[(2-fluoro-4-methoxyphenyl)methyl]-5′-methyl-1H-pyrazol-3′-O-β-D-glucopyranoside, a method for its preparation and the use thereof for preparing medicaments Human Necessities 0 Active
US12171767B2 Uses of DPP IV inhibitors Human Necessities 0 Active
US10080754B2 Uses of DPP IV inhibitors Human Necessities 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.